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Abstract: Endometriosis is a complex disease involving multiple susceptibility genes and environmental factors. Our pre-
vious studies on endometriosis identified a region of significant linkage on chromosome 10q. Two biological candidate 
genes (CYP17A1 and IFIT1) located on chromosome 10q, have previously been implicated in endometriosis and/or uter-
ine function. We hypothesized that variation in CYP17A1 and/or IFIT1 could contribute to the risk of endometriosis and 
may account for some of the linkage signal on chromosome 10q. We genotyped 17 single nucleotide polymorphisms 
(SNPs) in the CYP17A1 and IFIT1 genes including SNP rs743572 previously associated with endometriosis in 768 endo-
metriosis cases and 768 unrelated controls. We found no evidence for association between endometriosis and individual 
SNPs or SNP haplotypes in CYP17A1 and IFIT1. Common variation in these genes does not appear to be a major con-
tributor to endometriosis susceptibility in our Australian sample. 
INTRODUCTION 
 Endometriosis is a complex disease involving multiple 
susceptibility genes and environmental factors [1-4]. Esti-
mates of the population prevalence indicate that endometri-
osis affects 8–10% of women of reproductive age [2, 5], but 
the reasons for establishment and progression of endometri-
osis remain uncertain. 
 Our previous studies on endometriosis identified a region 
of significant linkage on chromosome 10q26 [6]. The peak 
linkage signal is located at 148.75 cM between markers 
D10S587 and D10S1656 and the 95% confidence interval 
(CI) spans a region of 8.5 megabase pairs (Mbp). Gene map-
ping of plausible candidates may help to define the mecha-
nisms contributing to the genetic susceptibility of endome-
triosis. Two candidate genes on chromosome 10q, which 
have previously been implicated in endometriosis and uter-
ine function, are cytochrome P450, family 17, subfamily A, 
polypeptide 1 (CYP17A1, MIM #609300) and interferon-
induced protein with tetratricopeptide repeats 1 (IFIT1, MIM 
#147690) [7-9]. 
 Human endometrium is highly responsive to hormonal 
stimuli during the menstrual cycle with estrogen and proges-
terone influencing maturational and functional changes in 
the endometrium. The CYP17A1 gene lies at 104.5 Mbp, on 
the shoulder of our linkage peak on chromosome 10 and en-
codes the cytochrome P450c17 enzyme that is involved in 
estrogen biosynthesis and metabolism [10]. The gene is ex-
pressed in human follicles, corpora lutea and endometrial 
carcinoma cells [11-13]. A number of studies on CYP17A1 
variation suggest it could be a genetic biomarker for hor-
mone related diseases [7, 14, 15]. One single nucleotide 
polymorphism (SNP, rs743572) at the -34 bp position rela-
tive to the start codon in the 5’UTR promoter region of  
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CYP17A1 has been commonly studied. The SNP was 
thought to be associated with a Sp-1 binding site that would 
lead to higher gene expression in male baldness [16]. In pa-
tients with endometrial cancer, a marked decrease in the A2 
allele of CYP17A1 was seen when compared with normal 
controls [7]. A subsequent study on 119 endometriosis cases 
and 108 normal controls demonstrated that the CYP17A1 
allele was associated with an increased risk of endometriosis 
in a Chinese population [8], but lack of association between 
endometriosis and the CYP17A1 polymorphism was ob-
served in UK and Japanese populations [17]. 
 The IFIT1 gene is located at 91.1 Mbp, close to the 
CYP17A1 locus just outside the 95% confidence region for 
our linkage peak. However the linkage peak is broad and 
there is evidence for linkage and association with endometri-
osis in Puerto Rican families at marker D10S677 [18], which 
is located at 113.34 cM (95.95 Mb) close to the IFIT1 locus. 
During early pregnancy, IFIT1 is highly expressed upon 
stimulation with interferon tau (IFNT), a type I interferon 
produced by the conceptus trophectoderm [9, 19]. As an en-
dometrial gene, IFIT1 is believed to respond to hormonal 
stimulation and may have a functional role for uterine sup-
port of peri-implantation conceptus survival, growth, and 
implantation [9]. Although IFIT1 has been studied in the 
sheep model, it is unknown if variants in IFIT1 contribute to 
risk of human endometriosis. 
 We previously excluded association between endometri-
osis and candidate genes under the linkage peak including 
empty spiracles homeobox 2 (EMX2), phosphatase and 
tensin homolog (PTEN) and fibroblast growth factor receptor 
2 (FGFR2) in our Australian sample [20, 21]. To continue to 
search for the gene or genes contributing to the linkage peak, 
we examined variation in IFIT1 and/or CYP17A1 to deter-
mine whether those genes contribute to the risk of endome-
triosis and may account for some of the linkage signal on 
chromosome 10q. 
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MATERIALS AND METHODS 
Participants and Sample Collection 
 The project was approved by the Human Research Ethics 
Committee of the Queensland Institute of Medical Research 
and the Australian Twin Registry. Women with surgically 
confirmed endometriosis were selected from each of 768 Aus-
tralian affected sister pair families as previously described 
[20]. The sister with the most severe stage of disease was cho-
sen for genotyping. Disease severity was assessed retro-
spectively from medical records using the revised American 
Fertility Society (rAFS) classification system [22]. Sixty one 
percent of cases were classified with minimal to mild endome-
triosis (rAFS stages I/II). The remaining 39% of cases with 
moderate to severe (rAFS stages III/IV) endometriosis were 
more likely to have ovarian endometriosis. A total of 645 
cases (84%) were diagnosed at laparoscopy; the remaining 
cases were mostly diagnosed at hysterectomy, or in a small 
number of cases at laparotomy or during another procedure. 
 The controls were 768 unrelated women who had volun-
teered for a twin study of gynaecological health [2]. Controls 
were selected after consideration of the competing issues of 
ascertainment bias from clinic controls and presence of undi-
agnosed cases. They were selected from women who self-
reported they had never been diagnosed with endometriosis 
and were therefore considered to be at low risk of having 
endometriosis. Twins had been asked simply ‘have you had 
endometriosis?’[2]. Additional information from medical 
records was used where available. Women were also asked 
whether they had ever had a laparoscopy and/or a hysterec-
tomy and the reasons for each. About 14% of control women 
reported having a hysterectomy and/or laparoscopy. No evi-
dence of endometriosis was reported at any of these proce-
dures in our control sample [20]. The mean ages (± SD) of 
the cases and controls at the time of data collection were 
35.6 ± 9.1 years (range = 17-65) and 45.7 ± 12.2 (range = 
29-90) years respectively. Genomic DNAs were extracted 
[23], and diluted to a working concentration of 2.5 ng/μl. 
The case and control DNAs were randomly placed in 384-
well PCR plates. 
SNP Selection 
 We selected 7 SNPs in the CYP17A1 gene based upon 
the allelic association results in endometriosis [8] and allele 
frequency information from the National Center for Biotech-
nology Information (NCBI, http://www.ncbi.nlm.nih.gov/). 
Ten SNPs were selected in the IFIT1 gene on the basis of 
the allelic frequency information and SNP distribution across 
the gene. The chosen CYP17A1 SNP list comprised two 
promoter, two intronic, two coding exonic and one 3’UTR 
SNPs. One 5’UTR promoter, seven intronic and two coding 
exonic SNPs were chosen in the IFIT1 gene. All SNP se-
quences were downloaded from the Chip Bioinformatics 
database (http://snpper.chip.org/) and the sequences were 
cross checked in NCBI and Sequenom RealSNP databases 
(https://www.realsnp.com/) before assay design. 
Genotyping 
 Multiplex assays were designed using the Sequenom 
MassARRAY Assay Design software (version 3.0). SNPs 
were typed using Sequenom iPLEX™ chemistry on a 
MALDI-TOF Mass Spectrometer. The 2.5 μL PCR reactions 
were performed in standard 384-well plates using 10 ng ge-
nomic DNA, 0.5 unit of Taq polymerase (Qiagen, Valencia, 
CA), 500 μmol of each dNTP, and 100 nmol of each PCR 
primers. Standard PCR thermal cycling conditions and post-
PCR extension reactions were carried out as described previ-
ously [24]. The iPLEX reaction products were desalted by 
diluting samples with 15l of water and adding 3l of resin. 
The products were spotted on a SpectroChip (Sequenom), 
and data were processed and analysed in a Compact Mass 
Spectrometer by MassARRAY Workstation (version 3.4) 
software (Sequenom). 
Statistical Analysis 
 The genotypes were inspected and results were tested for 
departures from Hardy-Weinberg equilibrium (HWE) sepa-
rately for cases and controls using Haploview version 3.32 
(Whitehead Institute for Biomedical Research, USA). The 
PLINK program (http://pngu.mgh.harvard.edu/purcell/ 
plink/) was used to test association between endometriosis 
and individual SNPs. Global p-values were obtained for each 
marker or each haplotype by performing 10,000 permutation 
tests. Haplotype frequencies, linkage disequilibrium (LD) 
estimates and analysis were determined by Haploview [25] 
using the default method of Gabriel [26]. A global p-value 
<0.05 was considered to be statistically significant. 
 We performed power calculations for our case-control 
study assuming a disease (endometriosis) prevalence of 10% 
using the Genetic Power Calculator [27]. Power calculations 
were based on 768 unrelated cases and 768 unrelated con-
trols using a significance threshold () of P = 0.01. 
RESULTS 
 Seven SNPs in the CYP17A1 gene and ten SNPs in the 
IFIT1 gene were typed in 768 endometriosis cases and 768 
unrelated controls. All SNPs were in Hardy–Weinberg equi-
librium. The minor allele frequencies of the CYP17A1 SNPs 
ranged from 0.230 to 0.414 in cases and from 0.200 to 0.443 
in controls. The minor allele frequencies of the IFIT1 SNPs 
ranged from 0.058 to 0.484 in cases and from 0.072 to 0.498 
in controls (Table 1). The minor allele frequency for the key 
SNP (rs743572) in the CYP17A1 gene was 0.386 and 0.397 
in cases and controls, respectively. There was no significant 
difference in allele frequency between cases and controls for 
this key SNP (Table 1). SNP rs2486758, at the -362 bp posi-
tion relative to the start codon in the 5’UTR promoter region 
of CYP17A1 gene showed nominal evidence of association 
(P < 0.05). However, the difference in allele frequency be-
tween cases and controls was small and the effects were not 
significant after correcting for multiple testing of all SNPs. 
 The positions of the SNPs genotyped in the IFIT1 gene 
and the CYP17A1 gene are shown in Fig. (1a). A linkage 
disequilibrium plot of SNPs and common haplotype blocks 
for the both genes are also shown in Fig. (1b,c). We found 
no evidence for association between endometriosis and indi-
vidual SNPs in either IFIT1 or CYP17A1 for either the allelic 
or the genotypic association tests (Table 1). 
 Stratification of cases according to stage of disease (469 
Stage A cases and 768 controls) gave a best point-wise P-
value of 0.02 for SNP rs619824 in the CYP17A1 gene, but 
the global result correcting for multiple tests was non-
significant (P = 0.58). Analysis of 296 cases diagnosed with 
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stage B and 768 controls, showed no significant differences 
between cases and controls for any SNPs typed in the study. 
DISCUSSION 
 Our results do not support an association between endo-
metriosis and common variation in either CYP17A1 or 
IFIT1. Although both genes are biological candidates for 
endometriosis and are located near the peak of our linkage 
signal on chromosome 10, there was no evidence that vari-
ants in either gene were associated with endometriosis or 
contribute to the linkage signal on chromosome 10q. 
 Genetic studies of CYP17A1 variants to date have fol-
lowed a defined biological hypothesis suggesting the 5’UTR 
promoter region SNP (rs743572) is associated with gene 
expression [16]. While the T allele (rs743572) was found to 
be associated with increased risk of endometriosis in a study 
of Chinese women [14], there was no association between 
CYP17A1 variants and endometriosis in studies in Brazilian, 
UK or Japanese populations [17, 28, 29]. Endometriosis is a 
sex steroid-dependent disease [30]. CYP17A1 is involved in 
estrogen biosynthesis and metabolism so that certain genetic 
polymorphisms in the gene could be associated with in-
creased risk of developing endometriosis. The differences in 
the results may relate to study power (sample size) or popu-
lation differences. We estimated power for our case-control 
study based on total sample of 768 cases and 768 controls. 
There is over 80% power to detect allele frequency of 0.05, 
0.25 and 0.5 contributing a dominant genotype relative risk 
(GRR) of 1.7, 1.5 and 1.8, respectively. In contrast, when the  
 
sample size changed to total sample of 100 cases and 100 
controls, there is only 10% power to detect allele frequency 
of 0.05, 0.25 and 0.5 contributing the similar genotype rela-
tive risk as stated above. These calculations demonstrate our 
sample has high power to detect novel gene associations of 
moderate effect. However, because our cases are highly se-
lected in terms of family history, compared to a standard 
case-control association study, our sample will have consid-
erably more power to detect gene associations. 
 We examined variation in CYP17A1 in cases from fami-
lies contributing to the linkage peak in this region of chro-
mosome 10q and genotyped 7 CYP17A1 SNPs including 
rs743572 in 768 endometriosis and 768 controls. We found 
no evidence for association with either SNP rs743572 in the 
promoter of CYP17A1 or the other 6 SNPs in the gene in our 
Australian sample. Strong linkage disequilibrium (LD) was 
detected between SNP rs743572 and the other three SNPs in 
the gene (rs3740397, r
2
=0.948; rs6163, r
2
=0.958; rs6162, 
r
2
=0.919) in our sample. It is unlikely that any asymptomatic 
cases present in the control samples would affect the conclu-
sion from this study for a disease with a prevalence of 8-10% 
[31]. 
 IFIT1 is a hormonally responsive gene expressed in 
sheep endometrium following stimulation with IFNT [9, 19]. 
To test for association between IFIT1 variants and human 
endometriosis we typed 10 common IFIT1 SNPs in our 768 
endometriosis cases and 768 unrelated controls. There was 
no evidence for association between the individual SNPs and 
endometriosis. Analysis of the SNPs across the IFIT1 locus  
 
Table 1. Association Analysis of 17 SNPs Across the IFIT1 and CYP17A1 Gene Locus Genotyped in 768 Endometriosis Cases and 
768 Controls 
 
dbSNP ID SNP Position Gene(s) Role Alleles MAF-Cases MAF-Controls 2 P Value OR 
rs304478 chr10:91140902 IFIT1 Promoter G>T 0.456 0.463 0.139 0.709 0.972 
rs303218 chr10:91142573 IFIT1 Intron G>A 0.175 0.186 0.620 0.431 0.929 
rs303217 chr10:91143679 IFIT1 Intron T>C 0.470 0.469 0.002 0.968 1.003 
rs303216 chr10:91145166 IFIT1 Intron C>T 0.169 0.182 0.858 0.354 0.915 
rs303215 chr10:91146811 IFIT1 Intron T>C 0.170 0.182 0.754 0.385 0.921 
rs304484 chr10:91149303 IFIT1 Intron G>T 0.231 0.244 0.770 0.380 0.928 
rs304485 chr10:91149890 IFIT1 Intron T>A 0.484 0.498 0.578 0.447 0.946 
rs303212 chr10:91151335 IFIT1 Intron T>C 0.232 0.241 0.357 0.550 0.950 
rs303211 chr10:91152477 IFIT1 Coding exon G>A 0.058 0.072 2.581 0.108 0.790 
rs303210 chr10:91152657 IFIT1 Coding exon C>T 0.169 0.182 0.822 0.365 0.916 
rs619824 chr10:104571278 CYP17A1 3' UTR G>T 0.414 0.443 2.633 0.105 0.888 
rs3740397 chr10:104582665 CYP17A1 Intron (boundary) C>G 0.375 0.396 1.404 0.236 0.916 
rs4919687 chr10:104585238 CYP17A1 Intron (boundary) G>A 0.347 0.359 0.539 0.463 0.946 
rs6163 chr10:104586914 CYP17A1 Coding exon C>A 0.376 0.395 1.058 0.304 0.926 
rs6162 chr10:104586971 CYP17A1 Coding exon G>A 0.389 0.403 0.573 0.449 0.945 
rs743572 chr10:104587142 CYP17A1 5' UTR T>C 0.386 0.397 0.376 0.540 0.954 
rs2486758 chr10:104587470 CYP17A1 5' UTR T>C 0.230 0.200 3.870 0.049 1.189 
MAF: minor allele frequency. 
dbSNP ID: database SNP identification. 
UTR: untranslated region. 
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Fig. (1). Variants typed in the human IFIT1 and CYP17A1 genes (a) the genomic structure of the IFIT1 and CYP17A1 genes showing the 
location of the 17 SNPs genotyped (b) the linkage disequilibrium plot of single nucleotide polymorphism estimated as 2 using Haploview 
(c) common haplotypes and association analysis with endometriosis. Shading key: white 2=0; shades of grey 0>2<1; black 2=1  
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showed strong linkage disequilibrium, with two haplotype 
blocks and three major haplotypes accounting for 87% of the 
chromosomes in our case samples. Our data also show strong 
linkage disequilibrium (LD) in two blocks covering most of 
the gene in our samples (Fig. 1b). We did not find any evi-
dence for association between SNP haplotype frequencies 
and endometriosis. IFIT1 may be important in uterine devel-
opment and function, but common variation is not associated 
with risk of endometriosis. 
 In this study, we examined the association between en-
dometriosis and individual common SNPs and haplotypes in 
the IFIT1 and CYP17A1 genes on chromosome 10q in an 
Australian population including a functional SNP in the 
CYP17A1 promoter region. Our data does not provide evi-
dence supporting an association between common variation 
in the IFIT1 and CYP17A1 genes and endometriosis suscep-
tibility. We have previously demonstrated significant linkage 
to endometriosis on chromosome 10q [6]. Results of the pre-
sent study demonstrate that variation in the CYP17A1 and 
IFIT1 genes does not explain linkage to endometriosis in this 
region of chromosome 10. Both genes are good candidates 
for endometriosis but the linkage region spans approximately 
8.5 million DNA base pairs and contains over 50 known 
genes within the 95% confidence interval for the linkage 
peak. Many of these other genes can also be considered can-
didates for endometriosis and variation in one or more of 
these genes may explain the linkage signal in this region. We 
conclude that common variants in the IFIT1 and CYP17A1 
genes do not play a key role in the pathogenesis of endome-
triosis. 
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